Safety, Tolerability, Pharmacokinetics and Efficacy of EYP001a in Patients With Nonalcoholic Steatohepatitis (NASH)

Clinical trial NCT03812029 · COMPLETED

Trial details

NCT number: NCT03812029
Sponsor: Enyo Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-alcoholic Steatohepatitis

Start date: 2019-01-30
Primary completion: 2021-06-16
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.